A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2004
11/17/2004	EP1476128A2 Lipase inhibiting composition
11/17/2004	EP1430111A4 Culture system for rapid expansion of human embryonic stem cells
11/17/2004	EP1392713A4 Liver x receptor agonists
11/17/2004	EP1390063B1 Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1311508B1 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1274700B1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1252322B1 Herpes virus strains for gene therapy
11/17/2004	EP1250340B1 Methods and compounds for inhibiting mrp1
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1214323B1 Indoloazepines as vasopressin receptor antagonists
11/17/2004	EP1185274B1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
11/17/2004	EP1176968B1 Selenium-containing pro-drugs for cancer therapy
11/17/2004	EP1156999B1 Method for the preparation of a chiral-beta-amino ester
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1137667B1 Analogues of glp-1
11/17/2004	EP1109809B1 Pyrroloquinolines for treatment of obesity
11/17/2004	EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004	EP1098885B1 Imidazole compounds and their use as adenosine deaminase inhibitors
11/17/2004	EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1075471B1 Indolyl derivatives as serotonergic agents
11/17/2004	EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004	EP1073427B1 Periadventitial delivery device
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP1054994B1 Fermentative preparation process for cytostatics and crystal forms thereof
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	EP1037649A4 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
11/17/2004	EP0981369B1 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/17/2004	EP0979245B1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/17/2004	EP0942732B1 Use of nk-1 receptor antagonists for treating movement disorders
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	EP0832092B1 Orally active adenosine kinase inhibitors
11/17/2004	EP0777491B1 Use of tasteless, hydrolysed collagen and agent containing the same
11/17/2004	EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004	CN1547608A Modified factor IX
11/17/2004	CN1547585A Inosine L-arginine salt and uses thereof
11/17/2004	CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v
11/17/2004	CN1547581A 二氮杂萘衍生物 Naphthyridine derivatives
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547578A Aminopyrrole compounds as antiinflammatory agents
11/17/2004	CN1547575A Novel phenylalkyl diamine and amide analogs
11/17/2004	CN1547484A Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/17/2004	CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy
11/17/2004	CN1547474A Skin-permeable selective cyclooxygenase-2 inhibitor composition
11/17/2004	CN1547471A Combination comprising combretastatin and anticancer agents
11/17/2004	CN1547433A Pesticidal formulation
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1546171A Protease inhibitor of Ornithotoctonus huwena
11/17/2004	CN1546135A Prescription and preparation and formulation of Lujing primordial qi strengthening capsule
11/17/2004	CN1546073A Preparation process of externally used traditional medicine powder resembled placebo
11/17/2004	CN1546068A Modified technique for making zedoary turmeric oil and glucose injection
11/17/2004	CN1546030A Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
11/17/2004	CN1546028A Furosemide compound injection for treating pigling edema disease
11/17/2004	CN1176072C Vitamin D3 analogs
11/17/2004	CN1176066C 1,1-and 1,2-disubsitituted cyclopropane compounds, preparation method thereof and drug compositions containing the same
11/17/2004	CN1175903C Preparation of deactivated dual vibrio vaccine for sea fish
11/17/2004	CN1175893C Medicine for treating hyperkinetic syndrome of children and its preparation method
11/17/2004	CN1175888C Er Beimu Capsule and its preparing process thereof
11/17/2004	CN1175853C Water-paste pills of traditional medicine for treating peripheral vascular disease
11/17/2004	CN1175838C Brain-invigorating tic-stopping medicine and its prepn.
11/17/2004	CN1175824C Application of non-denatured lactalbumin concentrated powder in the preparation of anti-anoxia health products
11/17/2004	CN1175807C Disulfide derivatives useful for treating allergic diseases
11/16/2004	US6818774 2-(s)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1h-isoquinolin -2-yl)- propionamide for example; alzheimer's disease or senile dementia
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818667 Obtained by fermenting the microorganism eurotium echinulatum delacroix (dsm 13872); inhibitors of kdr kinase, antiangiogenic agents suitable for preventing and/or treating malignant diseases
11/16/2004	US6818662 N-(3-chloro-4-morpholin-4-yl)phenyl-n'-hydroxyimidoformamidine containing sulfobutyl ether beta-cyclodextrin to increase the solubility; especially a freeze-dried injectable preparation.
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818646 1,2,3,4-tetrahydro-2-(5-(2-pyridinyl)-pyrimidin-2-yl)-3-(2,3 -dihydrobenzofuranyl)-9h-pyrrolo-(3,4-b)quinolin-9-one; male erectile dysfunction; sexual disorders
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818640 2-imino-1,3-thiazine derivatives
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818625 Method for increasing survival rate of cells in animal cell culture under hypoxia condition
11/16/2004	US6818622 Selective MMP inhibitors having reduced side-effects
11/16/2004	US6818619 Chimeric natriuretic peptides
11/16/2004	US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/16/2004	US6818208 Use of a flavonoid extract of ginkgo biloba substantially devoid of terpenes, in the dentibuccal field, and composition containing such extract
11/16/2004	CA2145383C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/16/2004	CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/16/2004	CA2074719C Calcium channel compositions and methods
11/11/2004	WO2004097019A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	WO2004096843A1 Polypeptide capable of assisting digestive organ absorption
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004096775A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
11/11/2004	WO2004096276A1 Sugar intake-ability enhancer
11/11/2004	WO2004096275A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096247A1 Instrument for inducing cytokine and method of inducing cytokine
11/11/2004	WO2004096246A1 Antiallergic composition
11/11/2004	WO2004096232A1 Interleukin-8 enhancer
11/11/2004	WO2004096209A1 The use of azetidinecarboxamide derivatives in therapy
11/11/2004	WO2004096198A1 Therapeutic agent
11/11/2004	WO2004011625A3 Polymorphisms for predicting disease and treatment outcome
11/11/2004	WO2003101380A3 Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors

1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1564